Group Clinical Visit Adherence Intervention for HIV+ Women of Color
Adherence, Patient, HIV/AIDS, Group Meetings
About this trial
This is an interventional other trial for Adherence, Patient focused on measuring HIV treatment, Adherence Group Treatment
Eligibility Criteria
Inclusion criteria:
- HIV-positive
- Cis gender women (assigned female sex at birth and current identifies as female)
- ≥ 18 years old
- English proficiency
- At least one visit to community health center where received HIV primary care within the last 12 months
- Self-reported ARV adherence <100% in the previous 30 days
- Most recent HIV viral load in last 12 months detectable
- Prescribed HIV medications for at least 16 weeks prior to detectable HIV viral load
- Currently prescribed HIV medications (i.e., current active HIV medication prescription in electronic medical record or pharmacy)
- Able to attend most/all group visits
Exclusion Criteria:
- Untreated severe mental illness including major depressive disorder, bipolar disorder, schizophrenia, psychosis, or current suicidal ideation.
- Acute intoxication
Sites / Locations
- Montefiore Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Sisters-GPS: Group Clinical Visits
Control: One-on-one Adherence Counseling
Those randomized to the Sisters-GPS arm will be expected to attend a total of seven group clinical visits, once a week for ~1.5 hours. Groups visits will include education, self-management skills development, and a clinical assessment by a medical provider with a focus on HIV treatment and adherence. Additionally, Sisters-GPS participants will be encouraged to participate in a private social media site specifically designed for the study, where participants will be able communicate with one another and with research staff. Group size will be 8-10 participants.
Those randomized to the control condition will receive an appointment with a HIV treatment adherence counselor and will be expected to attend a minimum of three adherence counseling visits. .